BUZZ-GeneDx appoints new CEO, shares rise
路透社2026/11/18 13:51November 18 - ** Shares of genomics company GeneDx (WGS.O) rose 3.1% to $48.8 in pre-market trading
** The company announced that Katherine Stueland (link) will step down as CEO after five years in the role
** Everett Cunningham has been appointed to replace Stueland as CEO, with the new CEO officially taking office on or before December 15
** WSG also reaffirmed its earnings forecast for fiscal year 2026
** Eight brokerages have given the stock a "buy" or higher rating; the median target price is $84 — LSEG data
** As of the previous trading day's close, the stock was down 63.6% for the year to date
(To assist non-English speakers, Reuters has automated the translation of its reports into several other languages. As automated translations may be inaccurate or miss required context, Reuters does not guarantee the accuracy of these automated translation texts and provides them solely for reader convenience. Reuters accepts no liability for any damage or loss caused by the use of the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
XRP Ledger independently validated through GL1 toolkit


British Pound weakens against Japanese Yen amid mixed UK economic data